Home>Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity
Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity
- Impact factors: 4.638
- Publication: BMC CANCER
- Author:Shi Yuan-Xiang, Yan Jian-Hua, Liu Wen, Deng Jun
- DOI citation-doi:10.1186/s12885-023-10895-2
- Date:2023-05-06